Cadence Bank Makes New $210,000 Investment in National Health Investors, Inc. (NYSE:NHI)

Cadence Bank purchased a new stake in shares of National Health Investors, Inc. (NYSE:NHI) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 2,500 shares of the real estate investment trust’s stock, valued at approximately $210,000.

Several other large investors have also made changes to their positions in NHI. Charles Schwab Investment Management Inc. boosted its position in shares of National Health Investors by 17.0% during the third quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust’s stock worth $71,651,000 after acquiring an additional 123,596 shares during the last quarter. Lasalle Investment Management Securities LLC grew its position in shares of National Health Investors by 8.4% during the first quarter. Lasalle Investment Management Securities LLC now owns 508,035 shares of the real estate investment trust’s stock valued at $31,920,000 after purchasing an additional 39,554 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. increased its holdings in shares of National Health Investors by 16.0% in the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust’s stock worth $32,034,000 after purchasing an additional 65,104 shares during the last quarter. Land & Buildings Investment Management LLC increased its holdings in shares of National Health Investors by 4.6% in the second quarter. Land & Buildings Investment Management LLC now owns 417,834 shares of the real estate investment trust’s stock worth $28,300,000 after purchasing an additional 18,232 shares during the last quarter. Finally, Sound Income Strategies LLC lifted its position in shares of National Health Investors by 10.8% in the third quarter. Sound Income Strategies LLC now owns 169,582 shares of the real estate investment trust’s stock worth $14,255,000 after buying an additional 16,463 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.

National Health Investors Stock Performance

NYSE NHI opened at $76.91 on Friday. National Health Investors, Inc. has a twelve month low of $51.59 and a twelve month high of $86.13. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 26.43, a PEG ratio of 5.14 and a beta of 1.05. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The stock has a 50-day moving average of $79.01 and a 200 day moving average of $74.68.

National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million for the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The business’s revenue was up 1.7% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.08 earnings per share. Sell-side analysts anticipate that National Health Investors, Inc. will post 4.42 EPS for the current fiscal year.

National Health Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 4.68%. The ex-dividend date is Tuesday, December 31st. National Health Investors’s dividend payout ratio is currently 123.71%.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. StockNews.com downgraded National Health Investors from a “buy” rating to a “hold” rating in a research note on Tuesday, October 15th. Wells Fargo & Company lowered shares of National Health Investors from an “overweight” rating to an “equal weight” rating and increased their price objective for the company from $81.00 to $86.00 in a research report on Tuesday, October 1st. Bank of America began coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 target price on the stock. Finally, Truist Financial lifted their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 30th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $76.33.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.